Comparison

CPI-169 racemate European Partner

Item no. TMO-T6809-1mg
Manufacturer TargetMol
CASRN 1450655-76-1
Amount 1 mg
Quantity options 100 mg 1 mL x 10 mM (in DMSO) 10 mg 1 mg 1 mL 25 mg 2 mg 50 mg 5 mg
Category
Type Molecules
Specific against other
Purity 0,98
Citations 1.Bradley WD,etal.EZH2 inhibitor efficacy in non-Hodgkin's lymphoma does not require suppression of H3K27 monomethylation.Chem Biol. 2014 Nov 20;21(11):1463-75.
Smiles CCS(=O)(=O)N1CCC(CC1)C(C)n1c(C)c(C(=O)NCc2c(OC)cc(C)[nH]c2=O)c2ccccc12
ECLASS 10.1 32169090
ECLASS 11.0 32169090
UNSPSC 12000000
Alias CPI 169,CPI-169,CPI169
Shipping Condition Cool pack
Available
Manufacturer - Targets
Epigenetic Reader Domain|||Histone Methyltransferase
Shipping Temperature
Cool pack
Storage Conditions
-20
Molecular Weight
528.66
Description
CPI-169 racemate (CPI 169) is a potent, and selective EZH2 inhibitor with IC50 of 0.24 nM, 0.51 nM, and 6.1 nM for EZH2 WT, EZH2 Y641N, and EZH1, respectively.
Pathways
Chromatin/Epigenetic

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 1 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close